Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lloyd Mabonga"'
Publikováno v:
Informatics in Medicine Unlocked, Vol 31, Iss , Pp 100993- (2022)
Core-splicing proteins such as small nuclear ribonucleoprotein polypeptide G (SNRPG) and retinoblastoma-binding protein 6 (RBBP6) have been in the spotlight for years because of their regulatory functions in mRNA processing and active engagement in c
Externí odkaz:
https://doaj.org/article/26e5e405f5834da4bccc32edb5e2b98e
Autor:
Rina Aharoni, Zulfiqar Ahmad, Suhail Akhtar, N. D. Prasad Atmuri, Carmen Avendaño, Ivneet Banga, Shai Bel, Łukasz Berlicki, Yair Blumberg, Carine Bourguet, Marlon Henrique Cardoso, Samraggi Choudhury, Sitan Diarra, Marvin N. Driessen, Michael K. Dunn, Vandon T. Duong, Offir Ertracht, Emer S. Ferro, Octavio Luiz Franco, Tatiana Galochkina, Sonu Gandhi, Shikun Ge, Jean-Christophe Gelly, Mayara C.F. Gewehr, Rujuta Ghorpade, Eric R. Gross, Wessal Hanout, Tamia A. Harris, Adrienne Joseph, Srinivasaraghavan Kannan, Abidemi Paul Kappo, Krishna Kumar, Maushmi S. Kumar, Dilraj Lama, Jolene L. Lau, Jianguo Li, Adi Litmanovich, Jamie Liu, William D. Lubell, Lloyd Mabonga, Subhasis Mahari, Priscilla Masamba, J. Carlos Menéndez, Gassan Moady, Satheesh Kumar Nanjappan, Ami Navon, Ines Neundorf, Meital Nuriel-Ohayon, Dmitriy Orlov, David Paul, Ron Piran, William Farias Porto, Nir Qvit, Samuel J.S. Rubin, Mussa Saad, Deepshikha Shahdeo, Olga Shamova, Kathleen M. Sicinski, Abhishek Singh, Worood Sirhan, Shruti Surendran, Simon Surprenant, Yaw Sing Tan, Mukesh Thakur, Ekaterina Umnyakova, Özge Ünsal, Chandra S Verma, Nana-Maria Wagner, Zhipeng A. Wang, Bryan J. Xie, Long Xu, Vanessa O. Zambelli, Xiaoying Zhang, Ji-Shen Zheng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd1766f7274d84b4d2ea94b9168ec00
https://doi.org/10.1016/b978-0-12-820141-1.00034-0
https://doi.org/10.1016/b978-0-12-820141-1.00034-0
Publikováno v:
Am J Transl Res
Dr Lloyd Mabonga, PhD
Dr Lloyd Mabonga, PhD
Regulatory core-splicing proteins are now becoming highly promising therapeutic targets for the development of anti-cancer drugs. SNRPG and RBBP6 are two good examples of regulatory core-splicing proteins involved in tumorigenesis and tumor developme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ae56e887503fd449efbffb1e43993cb2
https://europepmc.org/articles/PMC8661184/
https://europepmc.org/articles/PMC8661184/
Autor:
Lloyd Mabonga, Abidemi Paul Kappo
Publikováno v:
International Journal of Peptide Research and Therapeutics. 26:225-241
Protein–protein interactions (PPI) are vital in modulating biochemical pathways in many biological processes. Inhibiting PPI is a tremendously important diagnostic and therapeutic strategy in averting pathophysiological cues and disease progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8eb830afbe5e069be3726dddc98b10db
https://doi.org/10.1007/s10989-019-09831-5
https://doi.org/10.1007/s10989-019-09831-5
Modulating disease-relevant protein-protein interactions (PPIs) using small-molecule inhibitors is a quite indispensable diagnostic and therapeutic strategy in averting pathophysiological cues and disease progression. Over the years, targeting intrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed81aac6584f5230b32bd1dc1f297b3
https://europepmc.org/articles/PMC6682198/
https://europepmc.org/articles/PMC6682198/
Publikováno v:
Dr Lloyd Mabonga, PhD
Am J Transl Res
Am J Transl Res
Background: Targeting protein-protein interactions (PPIs) linked to protein quality control (PQC) pathways as potential anti-cancer drug targets have unanimously widened biological insights and the therapeutic potential of PPIs as smart-drug discover
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9a85fe99445b084a19eb8086cdeae350
https://e-century.us/files/ajtr/14/9/ajtr0142525.pdf
https://e-century.us/files/ajtr/14/9/ajtr0142525.pdf
Autor:
LLOYD MABONGA, Abidemi Paul Kappo
Publikováno v:
Dr Lloyd Mabonga, PhD
Small nuclear ribonucleoprotein polypeptide G (SNRPG), often referred to as Smith protein G (SmG), is an indispensable component in the biogenesis of spliceosomal uridyl-rich small nuclear ribonucleoprotein particles (U snRNPs; U1, U2, U4 and U5), wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9058974bc0f35fadbaacf0e7067dd23b
https://europepmc.org/articles/PMC6895504
https://europepmc.org/articles/PMC6895504
Publikováno v:
Dr Lloyd Mabonga, PhD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91d8d05f1c73216ae5743edc31a110c
https://books.google.co.za/books?id=WGJjEAAAQBAJ&lpg=PR5&ots=-T9RpdjabB&dq=lloyd%20mabonga%2C%20Peptide%20and%20Peptidomimetic%20Therapeutics%20From%20Bench%20to%20Bedside&pg=PR25#v=onepage&q=lloyd%20mabonga,%20Peptide%20and%20Peptidomimetic%20Therapeutics%20From%20Bench%20to%20Bedside&f=false
https://books.google.co.za/books?id=WGJjEAAAQBAJ&lpg=PR5&ots=-T9RpdjabB&dq=lloyd%20mabonga%2C%20Peptide%20and%20Peptidomimetic%20Therapeutics%20From%20Bench%20to%20Bedside&pg=PR25#v=onepage&q=lloyd%20mabonga,%20Peptide%20and%20Peptidomimetic%20Therapeutics%20From%20Bench%20to%20Bedside&f=false